scorecardresearch
Drug firm GSK Pharma's Q1 net profit rises 9% to Rs 121 crore

Drug firm GSK Pharma's Q1 net profit rises 9% to Rs 121 crore

The company had posted a net profit of Rs 110.83 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a regulatory filing

Shares of GlaxoSmithKline Pharmaceuticals Ltd closed at Rs 1,726.20 per scrip on BSE Shares of GlaxoSmithKline Pharmaceuticals Ltd closed at Rs 1,726.20 per scrip on BSE

Drug firm GlaxoSmithKline Pharmaceuticals on Monday reported a 9.24 per cent rise in consolidated net profit to Rs 121.08 crore for the quarter ended June 30, 2021. The company had posted a net profit of Rs 110.83 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a regulatory filing.

Consolidated revenue from operations of the company stood at Rs 789.99 crore for the quarter under consideration. It was Rs 648.59 crore for the same period a year ago, it added.

Shares of GlaxoSmithKline Pharmaceuticals Ltd closed at Rs 1,726.20 per scrip on BSE, up 2.65 per cent from the previous close.